Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 1 is a human genetic locus classified as a pseudogene, meaning it is a non-functional genomic sequence similar to a protein-coding gene but typically lacking the ability to code for a functional protein[2]. It is related to the parental gene PPIA, which encodes cyclophilin A, a peptidyl-prolyl cis-trans isomerase involved in protein folding, immune response, and other cellular processes[1][4]. Pseudogenes such as PPIAP1 may have regulatory functions at the RNA level, for example, acting as decoys for microRNAs or influencing the expression of their parental or other genes, but they are not considered therapeutic targets or druggable entities themselves[10]. Based on available evidence, PPIAP1 should not be considered a molecular target for drug development or biological research in the same manner as functional enzymes, receptors, or transporters. Its main biological relevance would likely be as a possible regulator at the RNA level, but this remains an area of basic research and not established clinical or translational medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 1 (PPIAP1).